Publikationen (69) Publikationen, an denen Forscher/innen teilgenommen haben

2024

  1. Bacteria–Fungi Interactions in Multiple Sclerosis

    Microorganisms, Vol. 12, Núm. 5

  2. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

  3. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

2023

  1. Analysis of a large case series of fatal familial insomnia to determine tests with the highest diagnostic value

    Journal of neuropathology and experimental neurology, Vol. 82, Núm. 2, pp. 169-179

  2. C9ORF72 Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia

    Journal of Personalized Medicine, Vol. 13, Núm. 9

  3. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  4. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

2022

  1. Blood β-Synuclein and Neurofilament Light Chain During the Course of Prion Disease

    Neurology, Vol. 98, Núm. 14, pp. e1434-e1445

  2. Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells

    Frontiers in Immunology, Vol. 12

  3. Laboratory Identification of Prion Infections

    Encyclopedia of Infection and Immunity (Elsevier), pp. 63-76

  4. Validation of the OPTIMIPARK Questionnaire: A Tool to Optimize Treatment in Parkinson's Disease

    Movement Disorders Clinical Practice, Vol. 9, Núm. 8, pp. 1085-1093

2021

  1. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population

    European Journal of Nutrition, Vol. 60, Núm. 5, pp. 2381-2396

  2. Bilateral facial nerve palsy associated with COVID-19 and Epstein–Barr virus co-infection

    European Journal of Neurology, Vol. 28, Núm. 1, pp. 358-360

  3. Delayed Neurological Improvement After Full Endovascular Reperfusion in Acute Anterior Circulation Ischemic Stroke

    Stroke, Vol. 52, Núm. 7, pp. 2210-2217

  4. Hemifacial spasm through the last three decades: From etiology to efficacy and safety of long-term botulinum toxin treatment

    Clinical Neurology and Neurosurgery, Vol. 203

  5. MRI findings in cervical spondylotic myelopathy with gadolinium enhancement: Review of seven cases

    BJR CASE REPORTS, Vol. 7, Núm. 2

  6. Neurologic Manifestations in a Prospective Unselected Series of Hospitalized Patients with COVID-19

    Neurology: Clinical Practice, Vol. 11, Núm. 2, pp. E64-E72

  7. Progressive Ataxia and Downbeat Nystagmus in an Adult

    JAMA Neurology

  8. Sporadic Creutzfeldt–Jakob disease with extremely long 14-year survival period

    European Journal of Neurology, Vol. 28, Núm. 9, pp. 2901-2906

2020

  1. A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 21, Núm. 3-4, pp. 252-262